We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bayer Hires Counsel To Look At Trasylol Disclosure

Law360 (October 16, 2006, 12:00 AM EDT) -- Bayer AG has appointed independent counsel to review the company’s failure to disclose to the U.S. Food and Drug Administration a study that revealed health risks posed by its heart surgery drug, Trasylol.

The company announced Friday that it had retained Fred F. Fielding from Wiley Rein & Fielding LLP to conduct a thorough investigation, and provide recommendations as to how Bayer should proceed.

“Bayer immediately initiated a full investigation into the matter and based on our investigation so far, we believe this was a serious...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.